Organization · Venture Capital
The Column Group
The Column Group (TCG) is a San Francisco-based venture capital firm specializing in early-stage life sciences investments, particularly in biotechnology. Founded in 2007, TCG supports the formation and growth of biotech companies through a comprehensive investment model.
Overview
What The Column Group does
What The Column Group is
The Column Group (TCG) is a San Francisco-based venture capital firm specializing in early-stage life sciences investments, particularly in biotechnology. Founded in 2007, TCG supports the formation and growth of biotech companies through a comprehensive investment model.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2007
- Approximate age
- About 19 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find The Column Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
The Column Group as a funder
Investment thesis
The Column Group focuses on forming and funding science-driven biotech companies capable of producing therapeutic breakthroughs, emphasizing long-term support from inception through exit.
Focus narrative
TCG employs an edge-to-edge investment model that supports early technology platforms, single assets, and later-stage programs from inception through exit. The organization operates through a variety of funds, including TCG Platform funds, TCG Opportunity funds, TCG Labs-Soleil, and TCG Crossover (TCGX). TCG primarily invests in the life sciences sector, with a focus on biotechnology and therapeutics.
Value beyond capital
TCG provides hands-on operating support, leadership recruitment, and company-building partnerships, emphasizing rigorous biology and chemistry diligence for scientific founders.
Focus and fit
- Stages
- Friends and Family · Angel · Pre-seed · Seed · Series A · Series B · Series C · Growth Equity · Pre-IPO
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 55
- Recorded notable exits
- Carmot Therapeutics, Peloton Therapeutics, Aragon Pharmaceuticals, Seragon Pharmaceuticals, Constellation Pharmaceuticals, and Exonics Therapeutics
Portfolio context
TCG has invested in and started 55 companies, leading to 18 successful exits. Notable portfolio companies include: Carmot Therapeutics: A clinical-stage company focused on innovative medicines, acquired by Roche for $3.3 billion. Peloton Therapeutics: An oncology-focused company acquired by Merck for up to $2.35 billion. Aragon Pharmaceuticals: Developed nuclear receptor targeting drugs, acquired by Johnson & Johnson for up to $1 billion. Seragon Pharmaceuticals: Focused on treatments for estrogen-driven cancers, acquired by Genentech for $800 million. Neurona Therapeutics: A cell therapy company targeting neuropsychiatric disorders. Constellation Pharmaceuticals: Acquired by MorphoSys for $1.7 billion, focused on epigenetic therapeutics. Exonics Therapeutics: Developed gene editing technologies for neuromuscular diseases, acquired by Vertex for up to $1 billion.
Common questions
What to know about The Column Group
Upseed classifies The Column Group under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.